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Hantaviruses belonging to the genus Orthohantavi-rus, family Hantaviridae, are frequently zoonotic. 
Rodents are the usual reservoirs of human pathogenic 
hantaviruses and typically do not show obvious signs 
of disease (1,2). Transmission to humans usually oc-
curs by inhalation of aerosols contaminated with 
urine or feces of infected reservoir animals (3). Hanta-
viruses are responsible for the severe illness hemor-
rhagic fever with renal syndrome (HFRS) and a mild-
er form, nephropathia epidemica (NE), as well as for 
hantavirus cardiopulmonary syndrome (HCPS) (1).
Recent studies have described the geographic 
distribution and host range of novel hantaviruses in 
Africa and the Indian Ocean (4–6). In Madagascar, 
hantavirus RNA was identified by molecular analysis 
in Rattus rattus and Eliurus majori rats from a forest 
site in Anjozorobe district. The virus was named An-
jozorobe virus (ANJZV) and is a genetic variant of 
Thailand orthohantavirus (THAIV) (5). In a more re-
cent national study, Raharinosy et al. detected hanta-
virus RNA in 12% (n = 897) of R. rattus rats, and all 
the sequences obtained grouped with ANJZV (7), but 
they did not detect hantavirus RNA in R. norvegicus 
rats (0%; n = 124) (7), a species commonly associated 
with the cosmopolitan Seoul orthohantavirus (1). Be-
cause THAIV may cause HFRS in Southeast Asia (8), 
ANJZV could also be a human pathogen in Mada-
gascar. In 1986, a limited study that used an immu-
nofluorescence assay with Hantaan orthohantavirus 
(HTNV) and Puumala orthohantavirus antigens was 
conducted in areas around the capital and reported 
low titer hantavirus antibodies in the serum samples 
of 7/18 rat catchers in Madagascar (9).
We conducted a national study to assess hantavi-
rus exposure in the general population of Madagas-
car. Sampling took place in conjunction with a recent 
rodent survey (7). In addition, because the original 
molecular hantavirus detection in Madagascar was 
from forest rodents (5), we also collected and analyzed 
human and rat samples from 4 sites close to forests.
The Study
As part of a retrospective national study on zoono-
ses, we collected human serum samples from 2011–
2013. We then randomly recruited 1,680 asymptom-
atic participants (851 female and 829 male; average 
age 37 years; range 18–99 years). We conducted sam-
pling in 28 sites, each with urban and rural zones; 
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We conducted a national human serologic study of a hanta-
virus detected in Madagascar rodents using a commercial 
kit and a new ELISA targeting the virus. Our results suggest 
a conservative estimate of 2.7% (46/1,680) IgG seropreva-
lence. A second single-district study using the new ELISA 
revealed a higher prevalence (7.2%; 10/139).
DISPATCHES
we sampled 60 persons per site, with 30 persons per 
zone (10). In addition, we used samples collected 
during 2015–2016 from 4 rural sites close to natural 
forest areas in Moramanga district, which is close 
to Anjozorobe district. For this study, we randomly 
selected 139 asymptomatic participants (31–36 per-
sons per site; average age 29 years, range 5–75 years). 
We also conducted trapping of the rat population in 
these 4 sites and randomly selected 237 R. rattus rats 
(58–61 per site).
The national ethics committee of Madagas-
car authorized human studies (authorization no. 
066-MSANP/CE on July 26, 2011; no. 049-MSANT/
CE on July 03, 2012). We conducted animal stud-
ies in accordance with Pasteur Institute animal use 
guidelines (https://www.pasteur.fr/en/file/2626/
download?token=YgOq4QW7). A committee of the 
Institut Pasteur de Madagascar approved the studies.
For the national study, we performed initial 
screening using the commercial Dobrava-Hantaan 
IgG EIA kit (Reagena Ltd, https://www.reagena.
com) based on the recombinant nucleocapsid (N) pro-
tein from HTNV. HTNV and THAIV, along with other 
Murinae-associated hantaviruses (Appendix Table 1, 
https://wwwnc.cdc.gov/EID/article/26/3/19-0320-
App1.pdf), exhibit close antigenic relationship (11). 
However, because 2-way cross-reactivity is not com-
plete (12), we developed a new IgG ELISA based on 
ANJZV recombinant N protein produced by a baculo-
virus-mediated insect cell expression system. We used 
this assay to test all samples testing positive or bor-
derline by the commercial kit and a subset of negative 
samples (Appendix). Based on the apparent increased 
detection ability of the ANJZV ELISA, we only used 
ANJZV ELISA for testing the human samples from 
the 4 sites close to forest areas.
After screening 1,680 serum samples with the 
commercial ELISA, we found 36 (2.1%) positive 
and 26 (1.5%) borderline samples. Using the custom 
ANJZV ELISA on these samples and a subset of 62 
negative samples, we found 46 positive and 15 bor-
derline (Appendix Tables 2, 3). Thus, the ELISA we 
developed specifically for ANJZV appeared to be 
more sensitive. To obtain a conservative estimate of 
seroprevalence, only samples testing positive by both 
assays or positive by 1 assay and borderline by the 
other were considered positive; testing yielded an 
overall prevalence of 2.7% (46/1,680; 95% CI 2.0%–
3.7%) in the population; 30 male (1.8%) and 16 female 
(0.9%) participants tested positive. 
Seropositive participants came from 20 of the 
28 study sites (0–13.3% per site) distributed all over 
Madagascar (Table 1; Figure). Univariate general-
ized linear mixed models with site-zone as random 
effect indicated no effect of age, sex, or location (ur-
ban or rural), but we did find a slight suggestion 
of increased exposure in sites where our previous 
study (7) had detected infected rats (OR 3.0, 95% CI 
0.78–11.5; p = 0.11).
The Moramanga sites, situated close to forest, 
had significantly higher seroprevalence rates (7.2%: 
10/139; 95% CI 3.7%–13.2%; range 3.2%–11.1%) than 
the national study sites (Kruskal-Wallis test χ21 = 4.65; 
p = 0.03) (Table 2; Figure). This finding may partly 
reflect the apparent higher sensitivity of the ANJZV 
ELISA used for the regional study. Because 2 (n = 62, 
3.2%) national samples tested negative by the com-
mercial ELISA were positive by ANJZV ELISA, and 
1,558 national samples were not tested by ANJZV 
ELISA, the overall national seroprevalence could be 
>2.7% (3.2% × 1,558 = 50; (50 + 46)/1,680 = 5.7%). 
Of interest, when we tested R. rattus rats from the 
4 Moramanga sites by nested reverse transcription 
PCR using a protocol described previously (Appen-
dix) (7), we also observed significantly higher infec-
tion rates than those for the national study sites; 77 of 
237 rat samples were positive (32.5%; 95% CI 26.7%–
38.9%; range 19.0%–43.3%; Kruskal-Wallis test 
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Table 1. Seroprevalence of hantavirus in humans in the 28 sites 
used for national study, Madagascar* 
Site 
no. Site 
No. positive/total no. participants 
(%;  95% CI) 
1 Antananarivo 8/60 (13.3; 6.3–25.1) 
2 Antsirabe 0/60 (0.0; 0.0–7.5) 
3 Anjozorobe 1/60 (1.7; 0.0–10.1) 
4 Tsiroanomandidy 3/60 (5.0; 1.3–14.8) 
5 Antsiranana 0/60 (0.0; 0.0–7.5) 
6 Sambava 2/60 (3.3; 0.5–12.5) 
7 Nosy-be 2/60 (3.3; 0.5–12.5) 
8 Mananjary 1/60 (1.7; 0.0–10.1) 
9 Ambositra 3/60 (5.0; 1.3–14.8) 
10 Farafangana 4/60 (6.7; 2.1–17.0) 
11 Ihosy 0/60 (0.0; 0.0–7.5) 
12 Fianarantsoa 1/60 (1.7; 0.0–10.1) 
13 Antsohihy 1/60 (1.7; 0.0–10.1) 
14 Mandritsara 0/60 (0.0; 0.0–7.5) 
15 Maevatanana 4/60 (6.7; 2.1–17.0) 
16 Ambato Boeny 0/60 (0.0; 0.0–7.5) 
17 Mahajanga 2/60 (3.3; 0.5–12.5) 
18 Moramanga 0/60 (0.0; 0.0–7.5) 
19 Toamasina 2/60 (3.3; 0.5–12.5) 
20 Ambatondrazaka 0/60 (0.0; 0.0–7.5) 
21 Miandrivazo 1/60 (1.7; 0.0–10.1) 
22 Ejeda 2/60 (3.3; 0.5–12.5) 
23 Morombe 1/60 (1.7; 0.0–10.1) 
24 Toliary 2/60 (3.3; 0.5–12.5) 
25 Taolagnaro 2/60 (3.3; 0.5–12.5) 
26 Ambovombe 2/60 (3.3; 0.5–12.5) 
27 Belo sur Tsiribihina 0/60 (0.0; 0.0–7.5) 
28 Morondava 2/60 (3.3; 0.5–12.5) 
Total  46/1,680 (2.7; 2.0–3.7) 
*Results from IgG testing by commercial ELISA and custom ELISA 
developed for Anjozorobe virus. 
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χ21 = 5.55; p = 0.02). These results further confirm a 
relatively high infection rate in the most abundant 
and widespread rodent in Madagascar. The small 
number of samples (2/61; 3%) negative by ANJZV 
ELISA but seropositive by the commercial ELISA 
could be explained by other Murinae-associated 
hantaviruses circulating in Madagascar.
Conclusions
Our results suggest the population of Madagascar is 
exposed to hantaviruses associated with the Murinae 
subfamily of rodents. The overall conservative preva-
lence estimate of 2.7% from the national-scale study, 
obtained using 2 ELISA assays, is similar to results from 
studies in some Africa countries where other confirma-
tory tests were used (3.9% in Cote d’Ivoire and 2.4% in 
the Democratic Republic of the Congo) (4,13). Although 
we believe some seropositive persons may have been 
exposed to other Murinae-associated hantaviruses, 
considering both ELISA results in humans and ro-
dent infection data together (7), our observations are 
consistent with evidence that most were exposed 
to ANJZV. Specifically, the ANJZV ELISA detected 
more seropositive persons than the commercial kit, 
and the cosmopolitan Seoul virus, if present in ro-
dents in Madagascar, is at low prevalence or patchily 
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Figure. Geographic distribution of IgG hantavirus human 
seroprevalence in Madagascar for the 28 sites of the 
national-scale study and (inset) for the 4 sites close to 
forest in Moramanga district. Maps were built with QGIS 
software version 3.8.0—Zanzibar (Open Source Geospatial 
Foundation Project, http://qgis.osgeo.org). Small inset map 
shows location of Madagascar off the coast of Africa. Details 
of results are provided in Tables 1 and 2.
 
Table 2. Seroprevalence of hantavirus in humans in the 4 sites 
close to forest in Moramanga district, Madagascar 
Site 
no. Site 
No. positive/total no. participants 
(%; 95% CI) 
I Mangidifoza 1/31 (3.2; 0.1–18.5) 
II Atsahatsaka 4/36 (11.1; 3.6–27.0) 
III Sahamalotra 3/36 (8.3; 2.1–23.6) 
IV Ambalafary 2/36 (5.5; 1.0–20.0) 
Total  10/139 (7.2; 3.7–13.2) 




distributed (7). Because hantavirus infection rates in 
R. rattus rats appear higher at sites close to forest, more 
widespread testing with the ELISA developed for An-
jozorobe virus is needed to confirm whether human 
communities in such areas are also at higher risk for 
infection. In addition, hospital surveillance studies 
are needed in Madagascar to determine if hantavirus 
infection occurs in patients, with testing focused on 
those with fever with unknown etiology, renal failure, 
or both.
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